Enteropathway: the metabolic pathway database for the human gut microbiota.


Journal

Briefings in bioinformatics
ISSN: 1477-4054
Titre abrégé: Brief Bioinform
Pays: England
ID NLM: 100912837

Informations de publication

Date de publication:
25 Jul 2024
Historique:
received: 10 04 2024
revised: 09 07 2024
accepted: 08 08 2024
medline: 2 9 2024
pubmed: 2 9 2024
entrez: 2 9 2024
Statut: ppublish

Résumé

The human gut microbiota produces diverse, extensive metabolites that have the potential to affect host physiology. Despite significant efforts to identify metabolic pathways for producing these microbial metabolites, a comprehensive metabolic pathway database for the human gut microbiota is still lacking. Here, we present Enteropathway, a metabolic pathway database that integrates 3269 compounds, 3677 reactions, and 876 modules that were obtained from 1012 manually curated scientific literature. Notably, 698 modules of these modules are new entries and cannot be found in any other databases. The database is accessible from a web application (https://enteropathway.org) that offers a metabolic diagram for graphical visualization of metabolic pathways, a customization interface, and an enrichment analysis feature for highlighting enriched modules on the metabolic diagram. Overall, Enteropathway is a comprehensive reference database that can complement widely used databases, and a tool for visual and statistical analysis in human gut microbiota studies and was designed to help researchers pinpoint new insights into the complex interplay between microbiota and host metabolism.

Identifiants

pubmed: 39222063
pii: 7747596
doi: 10.1093/bib/bbae419
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : JST AIP Acceleration Research
ID : JPMJCR19U3
Organisme : Japan Society for the Promotion of Science
ID : JP16H06279
Organisme : Japan Agency for Medical Research and Development
ID : JP21ck0106546h0002
Organisme : National Cancer Center Research and Development Fund
ID : 2020-A-7

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press.

Auteurs

Hirotsugu Shiroma (H)

School of Life Science and Technology, Tokyo Institute of Technology, 2-12-1 M6-3 Ookayama, Meguro-ku, Tokyo 152-8550, Japan.

Youssef Darzi (Y)

School of Life Science and Technology, Tokyo Institute of Technology, 2-12-1 M6-3 Ookayama, Meguro-ku, Tokyo 152-8550, Japan.
Omixer solutions, 4-7-15, Zaimokuza, Kamakura-shi, Kanagawa 248-0013, Japan.

Etsuko Terajima (E)

School of Life Science and Technology, Tokyo Institute of Technology, 2-12-1 M6-3 Ookayama, Meguro-ku, Tokyo 152-8550, Japan.

Zenichi Nakagawa (Z)

School of Life Science and Technology, Tokyo Institute of Technology, 2-12-1 M6-3 Ookayama, Meguro-ku, Tokyo 152-8550, Japan.

Hirotaka Tsuchikura (H)

School of Life Science and Technology, Tokyo Institute of Technology, 2-12-1 M6-3 Ookayama, Meguro-ku, Tokyo 152-8550, Japan.

Naoki Tsukuda (N)

School of Life Science and Technology, Tokyo Institute of Technology, 2-12-1 M6-3 Ookayama, Meguro-ku, Tokyo 152-8550, Japan.

Yuki Moriya (Y)

Database Center for Life Science, Joint Support-Center for Data Science Research, Research Organization of Information and Systems, 178-4-4 Wakashiba, Kashiwa-shi, Chiba 277-0871, Japan.

Shujiro Okuda (S)

Graduate School of Medical and Dental Sciences, Niigata University, 2-5274, Gakkocho-dori, Chuo-ku, Niigata City, Niigata 951-8514, Japan.

Susumu Goto (S)

Database Center for Life Science, Joint Support-Center for Data Science Research, Research Organization of Information and Systems, 178-4-4 Wakashiba, Kashiwa-shi, Chiba 277-0871, Japan.

Takuji Yamada (T)

School of Life Science and Technology, Tokyo Institute of Technology, 2-12-1 M6-3 Ookayama, Meguro-ku, Tokyo 152-8550, Japan.
Metagen, Inc., 246-2 Mizukami, Kakuganji, Tsuruoka, Yamagata 997-0052, Japan.
Metagen Theurapeutics, Inc., 246-2 Mizukami, Kakuganji, Tsuruoka, Yamagata 997-0052, Japan.
Digzyme, Inc., 2-2-1 Toranomon, Minato-ku, Tokyo 105-0001, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH